Insider Transactions in Q1 2024 at Baxter International Inc (BAX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 06
2024
|
Jeanne K Mason EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,630
+20.17%
|
-
|
|
Mar 06
2024
|
Reaz Rasul EVP,Group Pres, Healthcare |
BUY
Grant, award, or other acquisition
|
Direct |
83,353
+43.29%
|
-
|
|
Mar 06
2024
|
David S. Rosenbloom EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
53,584
+32.96%
|
-
|
|
Mar 06
2024
|
Alok Sonig EVP,Group President, Pharma |
BUY
Grant, award, or other acquisition
|
Direct |
83,353
+42.35%
|
-
|
|
Mar 06
2024
|
Brian Stevens SVP, CAO & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
14,289
+17.46%
|
-
|
|
Mar 06
2024
|
Christopher A. Toth EVP,Group Pres, Kidney Care |
BUY
Grant, award, or other acquisition
|
Direct |
119,076
+34.33%
|
-
|
|
Mar 06
2024
|
Joel T. Grade EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
42,867
+30.73%
|
-
|
|
Mar 06
2024
|
Jose E Almeida Chairman, CEO, President |
BUY
Grant, award, or other acquisition
|
Direct |
142,891
+36.85%
|
-
|
|
Mar 06
2024
|
Heather Knight EVP,Group Pres,Med Products |
BUY
Grant, award, or other acquisition
|
Direct |
107,168
+40.06%
|
-
|
|
Mar 06
2024
|
James W Borzi EVP,Chief Supply Chain Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,341
+32.99%
|
-
|
|
Mar 04
2024
|
James W Borzi EVP,Chief Supply Chain Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
420
-1.21%
|
$17,640
$42.5 P/Share
|
|
Mar 04
2024
|
Jeanne K Mason EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
475
-0.34%
|
$19,950
$42.5 P/Share
|
|
Mar 04
2024
|
Heather Knight EVP,Group Pres,Med Products |
SELL
Payment of exercise price or tax liability
|
Direct |
1,320
-2.42%
|
$55,440
$42.5 P/Share
|
|
Mar 04
2024
|
Reaz Rasul EVP,Group Pres, Healthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
522
-1.98%
|
$21,924
$42.5 P/Share
|
|
Mar 04
2024
|
Brian Stevens SVP, CAO & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
545
-1.01%
|
$22,890
$42.5 P/Share
|
|
Mar 04
2024
|
Jose E Almeida Chairman, CEO, President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,779
-4.47%
|
$200,718
$42.5 P/Share
|
|
Mar 01
2024
|
Heather Knight EVP,Group Pres,Med Products |
SELL
Payment of exercise price or tax liability
|
Direct |
2,154
-3.8%
|
$88,314
$41.01 P/Share
|
|
Mar 01
2024
|
Jeanne K Mason EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
963
-0.68%
|
$39,483
$41.01 P/Share
|
|
Mar 01
2024
|
Jeanne K Mason EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
64,488
-31.19%
|
$2,579,520
$40.61 P/Share
|
|
Mar 01
2024
|
Jeanne K Mason EVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
64,488
+23.77%
|
$2,386,056
$37.17 P/Share
|
|
Mar 01
2024
|
Reaz Rasul EVP,Group Pres, Healthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
1,538
-5.51%
|
$63,058
$41.01 P/Share
|
|
Mar 01
2024
|
David S. Rosenbloom EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,416
-2.49%
|
$58,056
$41.01 P/Share
|
|
Mar 01
2024
|
Alok Sonig EVP,Group President, Pharma |
SELL
Payment of exercise price or tax liability
|
Direct |
1,832
-5.74%
|
$75,112
$41.01 P/Share
|
|
Mar 01
2024
|
Brian Stevens SVP, CAO & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
673
-1.24%
|
$27,593
$41.01 P/Share
|
|
Mar 01
2024
|
Jose E Almeida Chairman, CEO, President |
SELL
Payment of exercise price or tax liability
|
Direct |
9,701
-8.33%
|
$397,741
$41.01 P/Share
|
|
Mar 01
2024
|
James W Borzi EVP,Chief Supply Chain Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
852
-2.39%
|
$34,932
$41.01 P/Share
|
|
Feb 12
2024
|
Heather Knight EVP,Group Pres,Med Products |
SELL
Payment of exercise price or tax liability
|
Direct |
356
-0.63%
|
$14,240
$40.31 P/Share
|
|
Feb 12
2024
|
Heather Knight EVP,Group Pres,Med Products |
BUY
Grant, award, or other acquisition
|
Direct |
1,027
+1.77%
|
-
|
|
Feb 12
2024
|
Reaz Rasul EVP,Group Pres, Healthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
248
-0.88%
|
$9,920
$40.31 P/Share
|
|
Feb 12
2024
|
Reaz Rasul EVP,Group Pres, Healthcare |
BUY
Grant, award, or other acquisition
|
Direct |
716
+2.48%
|
-
|
|
Feb 12
2024
|
Jeanne K Mason EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,463
-1.02%
|
$58,520
$40.31 P/Share
|
|
Feb 12
2024
|
Jeanne K Mason EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,602
+3.1%
|
-
|
|
Feb 12
2024
|
Brian Stevens SVP, CAO & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
284
-0.52%
|
$11,360
$40.31 P/Share
|
|
Feb 12
2024
|
Brian Stevens SVP, CAO & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
821
+1.48%
|
-
|
|
Feb 12
2024
|
Jose E Almeida Chairman, CEO, President |
SELL
Payment of exercise price or tax liability
|
Direct |
10,863
-8.53%
|
$434,520
$40.31 P/Share
|
|
Feb 12
2024
|
Jose E Almeida Chairman, CEO, President |
BUY
Grant, award, or other acquisition
|
Direct |
32,884
+20.52%
|
-
|
|
Feb 12
2024
|
James W Borzi EVP,Chief Supply Chain Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,311
-3.55%
|
$52,440
$40.31 P/Share
|
|
Feb 12
2024
|
James W Borzi EVP,Chief Supply Chain Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,184
+10.17%
|
-
|